Coya Therapeutics Announces that Results from a Double-Blind Placebo-Controlled Study in Alzheimer's Disease will be presented on October 29, 2024 at the Clinical Trials on Alzheimer's Disease Conference (CTAD24) in Madrid
Stock Information for Coya Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.